The Efficacy and Safety of High-Dose Intravenous Immunoglobulin in the Treatment of Kawasaki Disease: How Can We Predict Resistance to Intravenous Immunoglobulin Treatment of Kawasaki Disease?

被引：4
|
作者：
Han, Ji Whan [1 ]
机构：
[1] Catholic Univ Korea, Dept Pediat, Yeouido St Marys Hosp, Coll Med, 10,63-Ro, Seoul 07345, South Korea
来源：
KOREAN CIRCULATION JOURNAL | 2017年 / 47卷 / 02期
关键词：
GAMMA-GLOBULIN; THERAPY; MODULATE; SYSTEM;
D O I：
10.4070/kcj.2017.0011
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：179 / 181
页数：3
相关论文
共 50 条
  • [41] High-dose versus low-dose intravenous immunoglobulin for treatment of children with Kawasaki disease weighing 25 kg or more
    Suzuki, Takanori
    Michihata, Nobuaki
    Yoshikawa, Tetsushi
    Hata, Tadayoshi
    Matsui, Hiroki
    Fushimi, Kiyohide
    Yasunaga, Hideo
    EUROPEAN JOURNAL OF PEDIATRICS, 2020, 179 (12) : 1901 - 1907
  • [42] Intravenous immunoglobulin 1 g/kg as the initial treatment for Kawasaki disease
    Shiraishi, Hirohiko
    Iino, Mayu
    Hoshina, Masaru
    Ichihashi, Kou
    Momoi, Mariko Y.
    WORLD JOURNAL OF PEDIATRICS, 2007, 3 (03) : 195 - 199
  • [43] Calcineurin Inhibitor Treatment of Intravenous Immunoglobulin-Resistant Kawasaki Disease
    Tremoulet, Adriana H.
    Pancoast, Paige
    Franco, Alessandra
    Bujold, Matthew
    Shimizu, Chisato
    Onouchi, Yoshihiro
    Tamamoto, Alyson
    Erdem, Guliz
    Dodd, Debra
    Burns, Jane C.
    JOURNAL OF PEDIATRICS, 2012, 161 (03): : 506 - +
  • [44] Association between the timing of intravenous immunoglobulin treatment and severity of Kawasaki disease
    Iwasa, Mitsuji
    Aoki, Gaku
    Inukai, Sachiko
    MODERN RHEUMATOLOGY, 2025,
  • [45] Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin
    Suzuki, Hiroyuki
    Terai, Masaru
    Hamada, Hiromichi
    Honda, Takafumi
    Suenaga, Tomohiro
    Takeuchi, Takashi
    Yoshikawa, Norishige
    Shibuta, Shoichi
    Miyawaki, Masakazu
    Oishi, Ko
    Yamaga, Hironobu
    Aoyagi, Noriyuki
    Iwahashi, Seiji
    Miyashita, Ritsuko
    Onouchi, Yoshihiro
    Sasago, Kumiko
    Suzuki, Yoichi
    Hata, Akira
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2011, 30 (10) : 871 - 876
  • [46] Risk factors for failure of initial intravenous immunoglobulin treatment in Kawasaki disease
    Cha, Sungho
    Yoon, Minjeong
    Ahn, Yongjoo
    Han, Miyoung
    Yoon, Kyung-Lim
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2008, 23 (04) : 718 - 722
  • [47] Intravenous immunoglobulin treatment despite anaphylactic reaction in a child with Kawasaki disease
    David, Jacquier
    Thomas, Gehrke
    SWISS MEDICAL WEEKLY, 2012, 142 : 44S - 44S
  • [48] A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
    Weiguo Qian
    Yunjia Tang
    Wenhua Yan
    Ling Sun
    Haitao Lv
    Italian Journal of Pediatrics, 44
  • [49] A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
    Qian, Weiguo
    Tang, Yunjia
    Yan, Wenhua
    Sun, Ling
    Lv, Haitao
    ITALIAN JOURNAL OF PEDIATRICS, 2018, 44
  • [50] Predictors of Intravenous Immunoglobulin Resistance in Chinese Children with Kawasaki Disease
    Young, J. H. M.
    Huen, K. F.
    Chan, L. T. W.
    HONG KONG JOURNAL OF PAEDIATRICS, 2013, 18 (04) : 204 - 209
12345